The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.
Clinical trial NCT02430311 · COMPLETED
Trial details
- NCT number
- NCT02430311
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-10
- Primary completion
- 2016-07-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.